Intec Pharma Enters Phase I Clinical Trial With Its Third Pipeline Product
JERUSALEM, ISRAEL -- (Marketwired) -- 12/08/15 -- Intec Pharma Ltd. (NASDAQ: NTEC) (TASE: INTP), a clinical-stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill platform technology, today announced that it is …